Metabolic Signaling in the Tumor Microenvironment
Cancers · 06.01.2025 · 17 (1) · 155
DOI: 10.3390/cancers17010155 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 06.01.2025. Verfasst von Ryan Clay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 282 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Cancer cells must reprogram their metabolism to sustain rapid growth. This is accomplished in part by switching to aerobic glycolysis, uncoupling glucose from mitochondrial metabolism, and performing anaplerosis via alternative carbon sources to replenish intermediates of the tricarboxylic acid (TCA) cycle and sustain oxidative phosphorylation (OXPHOS). While this metabolic program produces adequate biosynthetic intermediates, reducing agents, ATP, and epigenetic remodeling cofactors necessary to sustain growth, it also produces large amounts of byproducts that can generate a hostile tumor microenvironment (TME) characterized by low pH, redox stress, and poor oxygenation. In recent years, the focus of cancer metabolic research has shifted from the regulation and utilization of cancer cell-intrinsic pathways to studying how the metabolic landscape of the tumor affects the anti-tumor immune response. Recent discoveries point to the role that secreted metabolites within the TME play in crosstalk between tumor cell types to promote tumorigenesis and hinder the anti-tumor immune response. In this review, we will explore how crosstalk between metabolites of cancer cells, immune cells, and stromal cells drives tumorigenesis and what effects the competition for resources and metabolic crosstalk has on immune cell function.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
ORCID-Profile: Ryan Clay, Kunyang Li
Förderung
- NCI NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Clay, R., Li, K., & Jin, L. (2025). Metabolic Signaling in the Tumor Microenvironment. Cancers, 17(1), 155. https://doi.org/10.3390/cancers17010155
Vancouver
Clay R, Li K, Jin L. Metabolic Signaling in the Tumor Microenvironment. Cancers. 2025;17(1):155. doi:10.3390/cancers17010155
BibTeX
@article{Clay2025,
author = {Clay, Ryan and Li, Kunyang and Jin, Lingtao},
title = {Metabolic Signaling in the Tumor Microenvironment},
journal = {Cancers},
year = {2025},
volume = {17},
number = {1},
pages = {155},
doi = {10.3390/cancers17010155}
}
EUVIMED